TIS tissue therapies limited

jm69 - they could reduce quarterly expenditure by $1 mill by...

  1. 2,243 Posts.
    lightbulb Created with Sketch. 109
    jm69 - they could reduce quarterly expenditure by $1 mill by reducing R & D and related expenditue over the next 2-3 quarters, defer US trials until 2014. Possibly do another small raise with a sophisticated shareholder (maybe pp?).
    If they were to do a largish CR in the next few months, it would be showing complete and utter contempt for LT holders IMHO....which unfortunately means they probably will do it on their record to date....
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.